GHRS Earnings Date: Nov 5, 2026 (Estimated) — GH Research PLC
NASDAQ · Healthcare · Biotechnology
Updated
When is GHRS's next earnings date?
GH Research PLC (GHRS) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.31.
How did GHRS do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), GH Research PLC posted EPS of -$0.23 versus the -$0.29 estimate, a beat of 28.1%. Revenue was $0. The stock's 1-day post-earnings move was +5.2%.
How much does GHRS stock move after earnings?
GHRS beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.7% (up or down) in the day after earnings.
About GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.29 | -0.23 | +28.12% | $0 | ✅ Beat | +5.18% | +3.81% | -4.15% |
| 2026-05-14 | Q1 2026 | -0.26 | -0.31 | -19.23% | $0 | ❌ Miss | +1.51% | +3.02% | -3.47% |
| 2026-03-05 | Q4 2025 | -0.28 | -0.23 | +17.86% | $0 | ✅ Beat | -5.13% | -5.38% | -8.88% |
| 2025-11-06 | Q3 2025 | -0.23 | -0.23 | +0.00% | $0 | ➖ Inline | -1.32% | +10.38% | +9.57% |
| 2025-02-27 | Q4 2024 | -0.22 | -0.17 | +22.73% | $0 | ✅ Beat | -2.92% | -5.10% | +11.67% |
| 2024-11-14 | Q3 2024 | -0.25 | -0.23 | +8.00% | $0 | ✅ Beat | -2.92% | +18.51% | -16.23% |
| 2024-09-03 | Q2 2024 | -0.23 | -0.20 | +13.04% | $0 | ✅ Beat | -6.57% | -19.05% | -38.95% |
| 2024-05-03 | Q1 2024 | -0.22 | -0.15 | +31.82% | $0 | ✅ Beat | +4.38% | +7.15% | +26.90% |
Showing last 8 quarters.